Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 5078565, 5 pages
https://doi.org/10.1155/2017/5078565
Clinical Study

Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study

1Department of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory for the Diagnosis and Treatment of Retinal and Choroid Diseases, Beijing, China
2Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China

Correspondence should be addressed to Yi Chen; moc.361@iynehcrd and Xiaoxin Li; moc.361@nixoaixilrd

Received 31 July 2016; Revised 26 January 2017; Accepted 27 February 2017; Published 9 April 2017

Academic Editor: Terri L. Young

Copyright © 2017 Qinrui Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Qinrui Hu, Yujing Bai, Xiaoli Chen, Lvzhen Huang, Yi Chen, and Xiaoxin Li, “Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study,” Journal of Ophthalmology, vol. 2017, Article ID 5078565, 5 pages, 2017. https://doi.org/10.1155/2017/5078565.